The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients.

about

The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients.

Item

http://www.wikidata.org/entity/Q38415030

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The clinical impact of staging ...... sessment of lymphoma patients.

@en

type

Item

label

The clinical impact of staging ...... sessment of lymphoma patients.

@en

prefLabel

The clinical impact of staging ...... sessment of lymphoma patients.

@en

P1476

The clinical impact of staging ...... sessment of lymphoma patients.

@en

P2093

Alexandra Smith

http://www.w3.org/2001/XMLSchema#string

Andrew Jack

http://www.w3.org/2001/XMLSchema#string

Dan Painter

http://www.w3.org/2001/XMLSchema#string

Eve Roman

http://www.w3.org/2001/XMLSchema#string

Ruth de Tute

http://www.w3.org/2001/XMLSchema#string

Simon Crouch

http://www.w3.org/2001/XMLSchema#string

P2860

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis.

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.

CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.

Revised response criteria for malignant lymphoma.

P304

175-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.13412

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25920510

http://www.w3.org/2001/XMLSchema#string